Impact of bone marrow minimal residual disease status on quality of organ response in systemic AL amyloidosis

Am J Hematol. 2022 Jul;97(7):E244-E246. doi: 10.1002/ajh.26562. Epub 2022 Apr 14.

Authors

Rajshekhar Chakraborty¹, Madeleine Hopson¹, Divaya Bhutani¹, George Vlad¹, Mathew S Maurer¹, Jan M Griffin¹, Markus Y Mapara¹, Jai Radhakrishnan¹, Suzanne Lentzsch¹

Affiliation

¹ Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.

PMID: 35385144
DOI: 10.1002/ajh.26562

No abstract available

Publication types

Letter

MeSH terms

Amyloidosis*
Bone Marrow
Humans
Immunoglobulin Light-chain Amyloidosis*
Neoplasm, Residual